Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2-Pentadecyl-2-oxazoline alleviates anxiety-like behaviour and modulates the microbiota-gut-brain axis in obese mice.

Frontiers in pharmacology·2026
Same author

Immunological consequences of senescence in physiology and pathology.

Journal of translational medicine·2026
Same author

Beyond Oral Anticoagulants Two Case Reports of Biopsy-Proven Heparin-Induced Anticoagulant-Related Nephropathy.

Nephron·2026
Same author

Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation.

Signal transduction and targeted therapy·2026
Same author

Impact of an Evidence-Based Bundle on Catheter-Associated Sepsis Incidence in Neonatal Intensive Care: A Quality Improvement Project.

Diseases (Basel, Switzerland)·2025
Same author

Uncovering the pleiotropic effects of oleoylethanolamide on obesity-driven chronic kidney disease in mice.

European journal of pharmacology·2025

Related Experiment Video

Updated: Jul 7, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

23.9K

A versatile method for the identification of senolytic compounds.

Chiara Annunziata1, Francesca Castoldi1, Schlegel Jan2

  • 1Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.

Cell Stress
|December 25, 2023
PubMed
Summary

Researchers developed a new senolytic assay to identify drugs that eliminate senescent cells. This method uses fluorescently tagged nuclei and spectral imaging, improving accuracy and overcoming limitations of existing techniques for aging research.

Keywords:
cell deathfluorescence microscopynavitoclaxnucleussenescence

More Related Videos

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.5K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K

Related Experiment Videos

Last Updated: Jul 7, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

23.9K
Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.5K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K

Area of Science:

  • Cell Biology
  • Aging Research
  • Drug Discovery

Background:

  • Senescent cells accumulate with age and contribute to age-related diseases.
  • Senolytics, drugs that eliminate senescent cells, are a promising therapeutic strategy.
  • Existing methods for senolytic identification have limitations, including high costs and interference from cellular autofluorescence.

Purpose of the Study:

  • To develop and validate a novel, high-content fluorescence microscopy-compatible assay for identifying senolytics.
  • To overcome limitations of current senolytic screening methods, particularly autofluorescence interference.

Main Methods:

  • Utilized spectral detector imaging to analyze autofluorescence differences between senescent and non-senescent cells.
  • Developed a senolytic assay involving co-culturing quiescent (GFP-tagged nuclei) and senescent (RFP-tagged nuclei) cells.
  • Validated the assay using known senolytics and confirmed results with flow cytometry.

Main Results:

  • Senescent cells exhibit higher autofluorescence than non-senescent cells, especially in the cytoplasm.
  • The novel assay successfully identified senolytic activity by detecting a reduction in RFP+ nuclei while leaving GFP+ nuclei unaffected.
  • The assay demonstrated cell type-specific senolytic effects, exemplified by fisetin's activity against senescent mouse cells but not human cells.

Conclusions:

  • The developed senolytic assay is effective, accurate, and overcomes limitations of previous methods.
  • This approach enables efficient genetic and chemical screening for novel senolytic compounds.
  • The assay's ability to capture cell type-specific effects is crucial for targeted senolytic drug development.